
Polar Leasing Adds an Ambient Temperature Pharmaceutical Storage Unit to Its Repertoire
Product is expected to maintain a steady temperature setting between 65°F (18°C) and 80°F (27°C).
Polar Leasing Company, Inc. (PLC), a provider of rental cold storage solutions for the pharma industry, has launched its validated
The Model A820 is a ground-resting, electric-powered outdoor model developed to maintain a consistent temperature setting between 65°F (18°C) and 80°F (27°C), independent of external weather conditions. This NSF-approved ambient temperature solution is expected to bring substantial cost savings by eliminating the need for refrigeration and reducing energy consumption, maintenance, and infrastructure expenses.
Bart Tippmann, president of Polar Leasing, notes that while the technology differs from the traditional cold storage designs that customers may come to expect, the company's goals to quality remain the same, explaining that "every Polar Leasing unit, including these state-of-the-art ambient temperature solutions, adheres to the same high-quality standards."
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.